{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:29:53Z","timestamp":1773008993001,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Haemophilia is an X\u2010linked bleeding disorder characterized by deficient or defective clotting factors. Obesity in persons with haemophilia (PwH) is associated with joint mobility issues, decreased range of motion and increased target joints. Complications of inhibitors, antibodies that neutralize clotting factor concentrate, can limit physical activity, potentially exacerbating obesity risk. This study examines the association between obesity and inhibitor status in PwH and explores the impact of emicizumab, a bispecific monoclonal antibody, on obesity trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort analysis of the American Thrombosis and Hemostasis Network ATHNdataset from 2013 to 2021 was conducted. The study included 19,074 males with haemophilia A or B with at least one recorded body mass index measurement. Statistical analyses included logistic regression, generalized estimating equations and difference\u2010in\u2010difference models to assess obesity trends and associations with inhibitors and emicizumab use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Obesity prevalence significantly increased in paediatric and adult PwH (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Children had a significantly increased risk of inhibitors compared to adults with either haemophilia A or B. A history of target joints and emicizumab use was associated with an increased obesity risk. No significant difference in obesity prevalence was found in adult or paediatric PwH with or without exposure to emicizumab. No significant association was observed between obesity and inhibitor status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Obesity prevalence in PwH continues to rise, aligning with trends in the general population. The link between target joints and obesity highlights the need to reduce obesity and improve joint health; future studies should explore causality and how physical activity mediates these associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hae.70139","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:36:34Z","timestamp":1760405794000},"page":"1226-1235","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibitors and Obesity: The Prevalence and Strength of Association in People With Haemophilia"],"prefix":"10.1111","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0340-0045","authenticated-orcid":false,"given":"Lisa","family":"Littner","sequence":"first","affiliation":[{"name":"Division of Hematology, Cancer and Blood Disease Institute Cincinnati Children's Hospital Medical Center  Cincinnati Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Hu","sequence":"additional","affiliation":[{"name":"American Thrombosis and Hemostasis Network  Hickory North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Manuel","sequence":"additional","affiliation":[{"name":"American Thrombosis and Hemostasis Network  Hickory North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Gerber","sequence":"additional","affiliation":[{"name":"American Thrombosis and Hemostasis Network  Hickory North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-9972","authenticated-orcid":false,"given":"Cristina","family":"Tarango","sequence":"additional","affiliation":[{"name":"Division of Hematology, Cancer and Blood Disease Institute Cincinnati Children's Hospital Medical Center  Cincinnati Ohio USA"},{"name":"University of Cincinnati College of Medicine  Cincinnati Ohio USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102516.2010.02400.x"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V108.11.4064.4064"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e328345f582"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02187.x"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13918"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12303"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102516.2010.02463.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1457"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23957"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14610"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002626"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.239160"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365\u20102516.2002.00680.x"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02400.x"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02509.x"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13877"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803550"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102364"},{"key":"e_1_2_11_20_1","unstructured":"U.S. Food and Drug Administration.FDA Approves Emicizumab\u2010kxwh for Hemophilia A With or Without Factor VIII Inhibitors(Accessed December 14 2024) https:\/\/www.fda.gov\/drugs\/drug\u2010approvals\u2010and\u2010databases\/fda\u2010approves\u2010emicizumab\u2010kxwh\u2010hemophilia\u2010or\u2010without\u2010factor\u2010viii\u2010inhibitors."},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1649378"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1703068"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30054-7"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14755"},{"key":"e_1_2_11_25_1","unstructured":"American Thrombosis and Hemostasis Network.Advancing Research With Better Data Through the ATHNdataset(December 15 2024) https:\/\/www.athn.org\/what\u2010we\u2010do\/national\u2010projects\/athndataset.html."},{"key":"e_1_2_11_26_1","volume-title":"Child & Teen BMI Categories","author":"Centers for Disease Control and Prevention"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022\u2010060640"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553\u20102712.2011.01185.x"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.13"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1201\/9781420035285"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1561\/0800000014"},{"issue":"158","key":"e_1_2_11_32_1","first-page":"1","article-title":"National Health and Nutrition Examination Survey 2017\u2013March 2020 Prepandemic Data Files\u2013Development of Files and Prevalence Estimates for Selected Health Outcomes","author":"Stierman B.","year":"2021","journal-title":"National Health Statistics Reports"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7037a3"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.21170"},{"key":"e_1_2_11_35_1","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases.Overweight & Obesity Statistics. September 2021. Accessed August 20 2025.https:\/\/www.niddk.nih.gov\/health\u2010information\/health\u2010statistics\/overweight\u2010obesity."},{"key":"e_1_2_11_36_1","volume-title":"What Causes Obesity and Overweight?","author":"Eurice Kennedy Shriver National Institute of Child Health and Human Development"},{"key":"e_1_2_11_37_1","unstructured":"U.S. Centers for Disease Control and Prevention. \u201cRisk Factors for Obesity\u201d. March 18 2024. Accessed August 21 2025.Risk Factors for Obesity | Obesity | CDC."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/08901171241233399"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15833-2"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00377-5"},{"key":"e_1_2_11_41_1","volume-title":"Factors for Obesity","author":"Centers for Disease Control and Prevention"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.70139","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.70139","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.70139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:38:33Z","timestamp":1773002313000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.70139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/hae.70139"],"URL":"https:\/\/doi.org\/10.1111\/hae.70139","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"2025-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}